Codes / ICD10CM / M1A.1191

M1A.1191 Lead-induced chronic gout, unspecified shoulder, with tophus (tophi)

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Lead-Induced Chronic Gout, Unspecified Shoulder, with Tophus (Tophi)

Summary

Lead-induced chronic gout is a form of arthritis caused by prolonged lead exposure, leading to elevated uric acid levels and recurrent joint inflammation. This specific presentation affects the shoulder (unspecified side) and includes the presence of tophi, which are deposits of urate crystals in soft tissues. Persistent symptoms and potential tissue damage may occur if untreated.

Causes

This condition results from chronic lead exposure, which disrupts uric acid metabolism and causes crystal accumulation in joints. Lead interferes with renal excretion of uric acid, leading to hyperuricemia and subsequent joint inflammation. Exposure sources include occupational contact, contaminated environments, or historical lead-based products.

Risk Factors

  • Long-term occupational or environmental lead exposure
  • History of gout or hyperuricemia
  • Male gender
  • Middle-aged or older adults
  • Presence of tophi (indicating chronic disease)

Symptoms

  • Recurrent episodes of intense joint pain in the shoulder
  • Persistent swelling, redness, and warmth in the affected area
  • Stiffness and limited shoulder mobility
  • Visible or palpable tophi (urate crystal deposits) in or around the shoulder
  • Flare-ups triggered by stress, diet, or illness

Diagnosis

Diagnosis involves clinical evaluation, laboratory tests, and imaging. Blood tests measure uric acid levels, while joint fluid analysis detects urate crystals. Imaging (e.g., X-rays or ultrasounds) assesses joint damage and confirms the shoulder as the affected site. Tophi may be identified through physical examination or imaging.

Treatment Options

Treatment focuses on reducing uric acid levels, managing pain, and addressing lead exposure. Medications include urate-lowering agents (e.g., allopurinol) and anti-inflammatory drugs. Tophi may require surgical removal in severe cases. Reducing or eliminating lead exposure is critical to prevent progression.

Prognosis and Follow-Up

With proper management, symptoms can be controlled, and joint damage may be minimized. Regular monitoring of uric acid levels and joint function is recommended. Untreated cases may lead to chronic pain, deformity, or further tophi formation.

Complications

  • Chronic joint damage or deformity
  • Persistent tophi growth
  • Increased risk of kidney stones or renal impairment
  • Recurrent gout flares affecting other joints

Lifestyle & Prevention

  • Avoid lead exposure (occupational or environmental)
  • Maintain a low-purine diet to reduce uric acid
  • Stay hydrated to support kidney function
  • Follow prescribed medication regimens consistently
  • Monitor and manage comorbidities (e.g., hypertension, diabetes)

When to Seek Professional Help

Seek care if experiencing severe joint pain, swelling, or redness that persists or worsens. Prompt evaluation is needed if tophi are noticed or if symptoms interfere with daily activities. Immediate medical attention is required for signs of infection or acute flare-ups.

Tips for Medical Coders

Use this code for lead-induced chronic gout affecting the shoulder (unspecified side) with documented tophi. Ensure documentation confirms the presence of tophi and the shoulder as the affected site. Code specificity requires distinguishing between unilateral (e.g., right/left) and unspecified shoulder involvement.

Book a walkthrough

M1A.1191 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.